D.G. Downey

Standards for the care of people with cystic fibrosis (CF); Planning for a longer life

ECFS standards of care on CFTR-related disorders: Identification and care of the disorders

Maternal and fetal outcomes in multiparous women with Cystic Fibrosis

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Pathogen eradication” and “Emerging pathogens”: difficult definitions in cystic fibrosis